249 related articles for article (PubMed ID: 25781649)
1. Potential treatments for genetic hearing loss in humans: current conundrums.
Minoda R; Miwa T; Ise M; Takeda H
Gene Ther; 2015 Aug; 22(8):603-9. PubMed ID: 25781649
[TBL] [Abstract][Full Text] [Related]
2. [Gene therapy for human hearing loss: challenges and promises].
Meyer A; Petit C; Safieddine S
Med Sci (Paris); 2013 Oct; 29(10):883-9. PubMed ID: 24148127
[TBL] [Abstract][Full Text] [Related]
3. Usher Syndrome in the Inner Ear: Etiologies and Advances in Gene Therapy.
de Joya EM; Colbert BM; Tang PC; Lam BL; Yang J; Blanton SH; Dykxhoorn DM; Liu X
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920085
[TBL] [Abstract][Full Text] [Related]
4. Altering gene expression using antisense oligonucleotide therapy for hearing loss.
Robillard KN; de Vrieze E; van Wijk E; Lentz JJ
Hear Res; 2022 Dec; 426():108523. PubMed ID: 35649738
[TBL] [Abstract][Full Text] [Related]
5. The application of genome editing in studying hearing loss.
Zou B; Mittal R; Grati M; Lu Z; Shu Y; Tao Y; Feng Y; Xie D; Kong W; Yang S; Chen ZY; Liu X
Hear Res; 2015 Sep; 327():102-8. PubMed ID: 25987504
[TBL] [Abstract][Full Text] [Related]
6. Clinical aspects of hereditary hearing loss.
Kochhar A; Hildebrand MS; Smith RJ
Genet Med; 2007 Jul; 9(7):393-408. PubMed ID: 17666886
[TBL] [Abstract][Full Text] [Related]
7. The applications of targeted delivery for gene therapies in hearing loss.
Jones M; Kovacevic B; Ionescu CM; Wagle SR; Quintas C; Wong EYM; Mikov M; Mooranian A; Al-Salami H
J Drug Target; 2023 Jul; 31(6):585-595. PubMed ID: 37211674
[TBL] [Abstract][Full Text] [Related]
8. Emerging Gene Therapies for Genetic Hearing Loss.
Ahmed H; Shubina-Oleinik O; Holt JR
J Assoc Res Otolaryngol; 2017 Oct; 18(5):649-670. PubMed ID: 28815315
[TBL] [Abstract][Full Text] [Related]
9. [Dawn of cutting-edge therapy for patients with hearing disorder].
Ikeda K
Nihon Yakurigaku Zasshi; 2013 Apr; 141(4):183. PubMed ID: 24046887
[No Abstract] [Full Text] [Related]
10. Fetal gene therapy and pharmacotherapy to treat congenital hearing loss and vestibular dysfunction.
Hastings ML; Brigande JV
Hear Res; 2020 Sep; 394():107931. PubMed ID: 32173115
[TBL] [Abstract][Full Text] [Related]
11. Antisense oligonucleotides as therapeutic agents.
Alama A; Barbieri F; Cagnoli M; Schettini G
Pharmacol Res; 1997 Sep; 36(3):171-8. PubMed ID: 9367660
[TBL] [Abstract][Full Text] [Related]
12. Hope for fixing gene defects.
Choi CQ
Sci Am; 2005 Dec; 293(6):65. PubMed ID: 16323691
[No Abstract] [Full Text] [Related]
13. Gene therapy for hearing loss.
Omichi R; Shibata SB; Morton CC; Smith RJH
Hum Mol Genet; 2019 Oct; 28(R1):R65-R79. PubMed ID: 31227837
[TBL] [Abstract][Full Text] [Related]
14. Antisense Oligonucleotides for the Treatment of Inner Ear Dysfunction.
Hastings ML; Jones TA
Neurotherapeutics; 2019 Apr; 16(2):348-359. PubMed ID: 30972560
[TBL] [Abstract][Full Text] [Related]
15. [Antisense oligonucleotides arrest the synthesis of disease promoting proteins].
Schnädelbach S
Med Monatsschr Pharm; 1998 Dec; 21(12):394-5. PubMed ID: 9925458
[No Abstract] [Full Text] [Related]
16. Rescue from hearing loss in Usher's syndrome.
Avraham KB
N Engl J Med; 2013 Oct; 369(18):1758-60. PubMed ID: 24171523
[No Abstract] [Full Text] [Related]
17. The genetics of hearing loss.
Aggarwal R; Saeed SR
Hosp Med; 2005 Jan; 66(1):32-6. PubMed ID: 15686164
[TBL] [Abstract][Full Text] [Related]
18. 'N of 1' therapies need a better model.
Aartsma-Rus A
Nat Med; 2021 Jun; 27(6):939. PubMed ID: 34031602
[No Abstract] [Full Text] [Related]
19. The Genomics of Auditory Function and Disease.
Taiber S; Gwilliam K; Hertzano R; Avraham KB
Annu Rev Genomics Hum Genet; 2022 Aug; 23():275-299. PubMed ID: 35667089
[TBL] [Abstract][Full Text] [Related]
20. Genetic Therapies for Hearing Loss: Accomplishments and Remaining Challenges.
Taiber S; Avraham KB
Neurosci Lett; 2019 Nov; 713():134527. PubMed ID: 31586696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
